U.S. Markets closed

Gilead shares drop on FDA concerns with similar Eli Lilly, Incyte drug

Gilead Sciences Inc. shares dropped 2.1% in moderate Thursday trade after a Food and Drug Administration briefing document raised safety questions about a similar Eli Lilly & Co. and Incyte Corp. drug. ...